X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (232) 232
Newspaper Article (157) 157
Publication (30) 30
Book Review (13) 13
Book / eBook (9) 9
Dissertation (5) 5
Book Chapter (1) 1
Conference Proceeding (1) 1
Magazine Article (1) 1
Paper (1) 1
Patent (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (118) 118
humans (103) 103
male (79) 79
female (76) 76
ophthalmology (64) 64
middle aged (43) 43
adult (38) 38
aged (36) 36
mutation (31) 31
macular degeneration (29) 29
retina (27) 27
eye diseases (25) 25
genetics & heredity (23) 23
pedigree (23) 23
studies (23) 23
adolescent (21) 21
analysis (20) 20
visual acuity (20) 20
genetic aspects (19) 19
animals (18) 18
disease (18) 18
ranibizumab (18) 18
risk factors (18) 18
aged, 80 and over (17) 17
genes (17) 17
genetics (17) 17
physiological aspects (16) 16
research (16) 16
young adult (16) 16
article (15) 15
blindness (15) 15
genetic structures (15) 15
intravitreal injections (15) 15
patients (15) 15
proteins (15) 15
abridged index medicus (14) 14
biochemistry & molecular biology (14) 14
child (14) 14
sense organs (14) 14
visual acuity - physiology (14) 14
dna mutational analysis (13) 13
fluorescein angiography (13) 13
vascular endothelial growth factor (13) 13
angiogenesis inhibitors - therapeutic use (12) 12
diabetic retinopathy (12) 12
economics (12) 12
mice (12) 12
phenotype (12) 12
retinal degeneration (12) 12
tomography, optical coherence (12) 12
age (11) 11
child, preschool (11) 11
homozygote (11) 11
gene mutations (10) 10
genomes (10) 10
genomics (10) 10
medicine, general & internal (10) 10
prevalence (10) 10
retinitis pigmentosa - genetics (10) 10
retinitis-pigmentosa (10) 10
treatment outcome (10) 10
care and treatment (9) 9
clinical trials (9) 9
degeneration (9) 9
eye proteins - genetics (9) 9
gene (9) 9
mutations (9) 9
research article (9) 9
retrospective studies (9) 9
risk (9) 9
united kingdom (9) 9
vascular endothelial growth factor a - antagonists & inhibitors (9) 9
wet macular degeneration - drug therapy (9) 9
bevacizumab (8) 8
capillary electrophoresis (8) 8
drug therapy (8) 8
eye (8) 8
follow-up studies (8) 8
genetic predisposition to disease (8) 8
genetic testing (8) 8
genotype (8) 8
health aspects (8) 8
membrane proteins - genetics (8) 8
mutation - genetics (8) 8
protein (8) 8
retinitis pigmentosa (8) 8
acuity (7) 7
consanguinity (7) 7
economic models (7) 7
hospitals (7) 7
medical research (7) 7
molecular sequence data (7) 7
mutation, missense (7) 7
phenotypes (7) 7
polymorphism, single nucleotide (7) 7
population (7) 7
retinal degeneration - genetics (7) 7
wet macular degeneration - physiopathology (7) 7
alleles (6) 6
asia (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
OISE - Stacks (1) 1
Robarts - Not Returned (1) 1
UTL at Downsview - May be requested (1) 1
United Church of Canada Archives - Archives (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Film-Philosophy, ISSN 1466-4615, 12/2015, Volume 19, Issue 1
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 2019, Volume 137, Issue 4, pp. 379 - 381
Late age-related macular degeneration (AMD) typically leads to visual impairment as a result of neovascular AMD or geographic atrophy (GA) or a combination of... 
OPHTHALMOLOGY | MACULAR DEGENERATION | RANIBIZUMAB | VEGF | TREAT-AND-EXTEND | Macular degeneration | Atrophy | Clinical trials | Eye diseases | Degeneration | Vascular endothelial growth factor | Age | Acuity | Vascularization | Index Medicus | Abridged Index Medicus
Journal Article
by Tedja, Milly S and Wojciechowski, Robert and Hysi, Pirro G and Eriksson, Nicholas and Furlotte, Nicholas A and Verhoeven, Virginie J. M and Iglesias, Adriana I and Meester-Smoor, Magda A and Tompson, Stuart W and Fan, Qiao and Khawaja, Anthony P and Cheng, Ching-Yu and Höhn, René and Yamashiro, Kenji and Wenocur, Adam and Grazal, Clare and Haller, Toomas and Metspalu, Andres and Wedenoja, Juho and Jonas, Jost B and Wang, Ya Xing and Xie, Jing and Mitchell, Paul and Foster, Paul J and Klein, Barbara E. K and Klein, Ronald and Paterson, Andrew D and Hosseini, S. Mohsen and Shah, Rupal L and Williams, Cathy and Teo, Yik Ying and Tham, Yih Chung and Gupta, Preeti and Zhao, Wanting and Shi, Yuan and Saw, Woei-Yuh and Tai, E-Shyong and Sim, Xue Ling and Huffman, Jennifer E and Polašek, Ozren and Hayward, Caroline and Bencic, Goran and Rudan, Igor and Wilson, James F and Aung, Tin and Veluchamy, Amutha B and Burdon, Kathryn P and Campbell, Harry and Chen, Li Jia and Chen, Peng and Chen, Wei and Chew, Emily and Deangelis, Margaret M and Ding, Xiaohu and Döring, Angela and Evans, David M and Feng, Sheng and Fleck, Brian and Fogarty, Rhys D and Fondran, Jeremy R and Fossarello, Maurizio and Guo, Xiaobo and Haarman, Annet E. G and He, Mingguang and Howe, Laura D and Janmahasatian, Sarayut and Jhanji, Vishal and Kähönen, Mika and Kaprio, Jaakko and Kemp, John P and Khaw, Kay-Tee and Khor, Chiea-Chuen and Krapohl, Eva and Korobelnik, Jean-François and Lee, Kris and Li, Shi-Ming and Lu, Yi and Luben, Robert N and Mäkelä, Kari-Matti and McMahon, George and Meguro, Akira and Mihailov, Evelin and Miyake, Masahiro and Mizuki, Nobuhisa and Morrison, Margaux and Nangia, Vinay and Oexle, Konrad and Panda-Jonas, Songhomitra and Pang, Chi Pui and Pirastu, Mario and Plomin, Robert and Rantanen, Taina and Schache, Maria and Seppälä, Ilkka and Smith, George D and Pourcain, Beate St and Tam, Pancy O and Tideman, J. Willem L and Timpson, Nicholas J and Vaccargiu, Simona and ... and UK Biobank Eye Vis Consortium and CREAM and 23andMe Res Team and CREAM Consortium and 23andMe Research Team and UK Biobank Eye and Vision Consortium and The CREAM Consortium
Nature Genetics, ISSN 1061-4036, 06/2018, Volume 50, Issue 6, pp. 834 - 848
Journal Article
Journal of Banking and Finance, ISSN 0378-4266, 10/2014, Volume 47, pp. 296 - 308
Asset market interconnectedness can give rise to significant contagion risks during periods of financial crises that extend beyond the risks associated with... 
Contagion | Financial crises | Exchange options | Delta hedging | TESTS | BUSINESS, FINANCE | MARKETS | ECONOMICS | OPTION PRICES | CRISES | Pricing | Studies | Economic models | Volatility | Rates of return | Risk assessment | Hedging | Economic crisis
Journal Article
Quantitative Finance, ISSN 1469-7688, 03/2019, Volume 19, Issue 3, pp. 473 - 490
Journal Article
American Journal of Ophthalmology, ISSN 0002-9394, 2017, Volume 180, pp. 64 - 71
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Index Medicus | Abridged Index Medicus | Klinisk medicin | Clinical Medicine
Journal Article